According to a report by Intel Market Research, the global Biotechnology market was valued at US$484.85 billion in 2023 and is projected to reach US$824.31 billion by 2030, growing at a CAGR of 7.8% during the forecast period. Biotechnology uses biological systems, organisms and derivatives to develop or modify products and processes across health, agriculture, industry and environmental management. The field integrates molecular biology, genetics, microbiology, biochemistry and bioinformatics and is being reshaped by advances in genetic engineering, personalized medicine, synthetic biology and digital biology.
Explore the full report: https://www.intelmarketresearch.com/Biotechnology-Market-Global%20-2802
Why Is Demand Increasing?
- Advances in genetic engineering, molecular biology and personalized medicine are expanding biotechnology applications across healthcare.
- Growing use of genomics, AI-driven analytics and targeted therapies is creating opportunities for precision and personalized medicine.
- Government support and biotechnology infrastructure investment in emerging economies are broadening the geographic base of research and commercialization.
Biotechnology Innovation & Biomanufacturing Watch
Biotechnology competition is increasingly defined by platform technologies, strategic partnerships, investment and commercialization capability. The report highlights activity in gene therapy, synthetic biology, stem-cell research, AI-driven drug discovery and digital biology. It also describes significant deal activity, including Johnson & Johnson’s announced US$14.6 billion acquisition of the maker of Caplyta and Eli Lilly’s agreement to acquire CRISPR biotech Verve Therapeutics for up to US$1.3 billion. At the same time, regulatory complexity and ethical considerations can extend development timelines, making regulatory agility and collaboration important elements of the industry’s competitive environment.
Segmentation Highlights
- By technology: DNA Sequencing, Cell-Based Assays, CRISPR and Gene Editing, Fermentation Technology, Nanobiotechnology, Tissue Engineering & Regeneration, PCR, Recombinant Technology, Chromatography & Spectroscopy and Others.
- By application: Healthcare & Medical Biotechnology, Agricultural Biotechnology, Industrial Biotechnology, Environmental Biotechnology and Food & Beverage Biotechnology.
- Healthcare applications include drug discovery and development, vaccine development, gene therapy and personalized medicine.
- Industrial applications include biofuels, bioplastics, enzymes and biocatalysts, while environmental applications include waste treatment, bioremediation and pollution monitoring.
- By end user: Pharmaceutical & Biotech Companies, Academic & Research Institutes, CROs, Hospitals & Diagnostic Labs, Agricultural & Environmental Organizations and Food & Beverage Companies.
Regional Outlook
- North America leads through innovation, funding, commercialization capacity, research institutions and venture capital access.
- Europe remains a major biotechnology center, with strong activity in Germany, the UK, Switzerland, France and the Netherlands.
- Asia-Pacific is the fastest-growing region, supported by healthcare demand, government investment and an expanding biotechnology ecosystem.
- Latin America and the Middle East & Africa are developing markets with growing infrastructure and government-supported initiatives.
Download the free sample report: https://www.intelmarketresearch.com/download-free-sample/2802/Biotechnology-Market-Global
Why This Market Matters
Biotechnology has expanded from a specialized research field into a broad industrial platform supporting healthcare, agriculture, manufacturing, environmental management and food applications. The report’s market scope reflects this breadth, covering technologies from DNA sequencing and PCR to CRISPR, fermentation, recombinant technology and tissue engineering. Healthcare remains an important area, particularly through drug discovery, vaccines, gene therapy and personalized medicine, while industrial and environmental applications broaden the commercial opportunity. Emerging markets are also investing in research capabilities and infrastructure, creating new centers of biotechnology activity alongside established North American and European ecosystems.
Competitive Landscape
- Johnson & Johnson — Included among the major biotechnology companies profiled in the report.
- Roche — A major biotechnology and healthcare company included in the competitive landscape.
- Pfizer — Profiled among leading biotechnology market participants.
- Merck — Included among the major companies covered in the report.
- Sanofi — Profiled as a key participant in the global biotechnology market.
View the full report: https://www.intelmarketresearch.com/Biotechnology-Market-Global%20-2802
FAQ
Q: What is the biotechnology market size?
A: The global biotechnology market was US$484.85 billion in 2023 and is projected to reach US$824.31 billion by 2030 at a 7.8% CAGR.
Q: Which region leads biotechnology?
A: North America leads the global biotechnology industry, while Asia-Pacific is identified as the fastest-growing region.
Q: Which technologies are covered?
A: The report covers DNA sequencing, cell-based assays, CRISPR and gene editing, fermentation, nanobiotechnology, tissue engineering, PCR, recombinant technology and chromatography and spectroscopy.
Biotechnology’s commercial scope is unusually broad because the same underlying biological capabilities can be applied across multiple industries. The report connects advances in genomics, gene editing, synthetic biology and bioinformatics with healthcare applications, while also covering agriculture, industrial processes, environmental management and food production. Personalized medicine represents an important opportunity because genomic information and AI-based analytics can support more targeted approaches. Emerging economies are investing in infrastructure, workforce development and research capabilities, creating additional centers of activity. At the same time, regulatory review, ethical considerations and commercialization timelines can influence investment decisions. Strategic collaborations and acquisitions are therefore important mechanisms for accessing technologies and strengthening pipelines. The market’s outlook reflects both scientific progress and the ability of companies and institutions to translate biological innovation into scalable products and services.
What Does the Full Report Cover?
The full biotechnology study provides market-size and forecast analysis together with a broad technology, application and end-user framework. It covers healthcare and medical biotechnology, agriculture, industrial biotechnology, environmental biotechnology and food and beverage applications. Regional analysis spans North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa, including the major countries and biotechnology ecosystems described in the report. The competitive landscape profiles major companies and tracks the strategic environment around innovation, investment, acquisitions and partnerships. The report also examines regulatory challenges, personalized medicine, emerging-market expansion and the role of AI, genomics and advanced biological technologies in future development.
View the complete report: https://www.intelmarketresearch.com/Biotechnology-Market-Global%20-2802
Related Reports
- PRRS Vaccines — https://www.intelmarketresearch.com/prrs-vaccines-market-market-21425
Cancer Respiratory Biopsy — https://www.intelmarketresearch.com/cancer-respiratory-biopsy-market-3188
About Intel Market Research
Intel Market Research provides quantified market intelligence covering market size, forecasts, segmentation, regional analysis, competitive landscapes, market dynamics, technology and stakeholder insights. The supplied report pages describe coverage based on primary and secondary research and provide global and regional market perspectives for the stated forecast periods.
Contact Details
Website: www.intelmarketresearch.com | Asia-Pacific: +91 9169164321
